Otero Jose Manuel's Form 4/A amendment
AmendedLexeo Therapeutics, Inc. (LXEO) · filed Feb 20, 2026
- Accession no.
- 0002024096-26-000004
- Filed
- Feb 20, 2026
- Trade date
- Nov 18, 2025
- Filing delay
- 94 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 20, 2025
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $6.68K. It was filed 94 days after the trade.
This amendment replaces 0002024096-25-000005 (filed Nov 20, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Otero Jose ManuelCIK 0002024096 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Common Stock | SSaleDisposed | −721 | $9.27 | −$6,683.67 | 63,476 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.